The purpose of this report was to compare lower extremity amputation rates between areas of the United States and areas outside the United States using a standard format. Twelve U.S. counties similar in size, income, and land use were selected. The rate of amputation for each county was developed following the method and definitions described by the Global Lower Extremity Amputation Study (GLEAS). The data were compared to rates of amputation for non-U.S. areas that participated in the GLEAS. The U.S. counties generally had higher amputation rates than the non-U.S. areas in this standardized comparison. The United States suffers a high number of lower extremity amputations in comparison to other developed countries. The effectiveness of prevention strategies in the United States needs to be reevaluated and new strategies explored.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10016-006-9044-9DOI Listing

Publication Analysis

Top Keywords

lower extremity
16
united states
16
extremity amputation
12
amputation rates
12
areas united
8
non-us areas
8
amputation
6
international comparison
4
lower
4
comparison lower
4

Similar Publications

Obesity is a leading cause of cardiovascular diseases. There are significant and mutual associations between lymphatic dysfunction and obesity. This case-control study aimed to compare nutrient intake, depressive symptoms, and Eysenck's personality traits in patients with lower extremity lymphedema and overweight/obesity (n = 34) in comparison to patients with lifestyle-induced overweight/obesity (n = 30) and patients with normal body weight (n = 30).

View Article and Find Full Text PDF

Objectives: Studies comparing alternative autologous vein grafts (AAVG) to single-segment great saphenous vein (ssGSV) grafts report mixed results. The status of AAVG as first choice when ssGSV is unavailable is not unequivocal, based on current evidence. Our study compares results between AAVG and ssGSV in lower extremity bypass surgery.

View Article and Find Full Text PDF

Omniflow prosthesis for treatment prosthetic graft infection of the aorto-iliac and femoropopliteal level on the infrarenal aortic segment and lower extremity.

Ann Vasc Surg

January 2025

Department of for Cardiovascular Surgery, University Heart Centre Freiburg - Bad Krozingen, University Medical Centre Freiburg, Freiburg, Germany; Faculty of Medicine, Albert Ludwigs University Freiburg, Freiburg, Germany.

Objectives: To report outcomes after the use of the Omniflow II biosynthetic graft (LeMaitre Vascular, Il, USA) for vascular reconstruction in patients with prosthetic infection at the aorto-iliac and femoropopliteal level.

Methods: Within a six-year period, all consecutive patients with aorto-iliac and femoro-popliteal graft infection treated by resection of the infected graft material, extensive local debridement and reconstruction using Omniflow II biosynthetic graft were retrospectively analzyed. Patient characteristics, intraoperative details, postoperative outcomes, and infection details were assessed.

View Article and Find Full Text PDF

Acellular Dermal Matrices in Reconstructive Pediatric Complex Lower Limb Trauma: An Observational Study.

J Trauma Nurs

January 2025

Author Affiliations: St Andrew's Anglia Ruskin (StAAR) Research Group, Faculty of Health, Education, Medicine, and Social Care, Anglia Ruskin University, Chelmsford, UK (Dr Adegboye); Division of Plastic and Reconstructive Surgery, Red Cross War Memorial Children's Hospital; and Division of Plastic & Reconstructive Surgery, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa (Dr Pillay and Prof Adams).

Background: Contemporary research has shown that acellular dermal matrices can benefit adult lower extremity traumatic injuries; however, its use in children has not been explored.

Objective: This study aims to explore the use of acellular dermal matrices in pediatric complex lower extremity trauma.

Methods: This single-center retrospective observational cohort study of children with complex lower extremity trauma treated with Pelnac™, commercial acellular dermal matrices, was conducted at a tertiary hospital in South Africa from 2010 to 2017.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!